mHealth App for HIV with Substance Use Disorder

Recruiting in Palo Alto (17 mi)

+7 other locations

Overseen byRyan Westergaard

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Wisconsin, Madison

No Placebo Group

Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?The current protocol aims to enroll up to 806 participants from 8 study sites in a clinic-supported intervention which will connect them to Vivent Health care team and a cohort of peer mentors for a year-long intervention period to support patient HIV care to maintain viral suppression and clinic appointments.

Eligibility Criteria

This trial is for people living with HIV who have struggled to keep their virus levels low or attend clinic appointments due to substance use. Participants must be able to read and write in English, have missed HIV care appointments, or have a history of substance use disorders. They need a smartphone and the ability to consent.

Inclusion Criteria

Your HIV RNA levels have exceeded 200 copies/ml in the past year.

Individuals aged 18 years or older, with HIV RNA levels below 200 copies/ml in the past months, no missed visits and negative responses to screening questions about unhealthy alcohol or substance use who have a history of substance abuse disorder or treatment services listed on their patient problem list are eligible.

You satisfy at least one of the following criteria:

+5 more

Exclusion Criteria

I have a smartphone or am willing to get one for this study.

I am able to understand and make decisions about my health care.

Participant Groups

The trial tests the 'Connections App', which connects patients with an HIV care team and peer mentors for one year. The goal is to help participants maintain viral suppression and improve attendance at clinic appointments through this mobile health intervention.

4Treatment groups

Experimental Treatment

Group I: Group 4: mHealth ImplementationExperimental Treatment1 Intervention

Next 2 sites begin enrollment 6 months after Group 3. Research participants will be asked to complete weekly-check-in, 4 research surveys and engage in content available in the Connections app and with peer mentors over the course of a year.

Group II: Group 3: mHealth ImplementationExperimental Treatment1 Intervention

Next 2 sites begin enrollment 6 months after Group 2. Research participants will be asked to complete weekly-check-in, 4 research surveys and engage in content available in the Connections app and with peer mentors over the course of a year.

Group III: Group 2: mHealth ImplementationExperimental Treatment1 Intervention

Next 2 sites begin enrollment 6 months after Group 1. Research participants will be asked to complete weekly-check-in, 4 research surveys and engage in content available in the Connections app and with peer mentors over the course of a year.

Group IV: Group 1: mHealth ImplementationExperimental Treatment1 Intervention

First 2 sites begin enrollment. Research participants will be asked to complete weekly-check-in, 4 research surveys and engage in content available in the Connections app and with peer mentors over the course of a year.

Connections App is already approved in United States for the following indications:

🇺🇸 Approved in United States as Connections App for: